AzTrials
AzTrials

Hemodynamic InstabilityRELAX-LAPNCT04076709

Cardiovascular Effects of Muscle Relaxation During Laparoscopic Surgery

A study testing goal directed anaesthesia in people with Hemodynamic Instability, run by Leiden University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many surgical procedures are performed using the laparoscopic approach. However, insufflation of the abdomen (pneumoperitoneum) has detrimental hemodynamic effects. The investigators intend to investigate the effect of deep neuromuscular block and nociception guided anaesthesia on hemodynamic variables during… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hemodynamic Instability
What is being tested?
goal directed anaesthesia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteNetherlands
Study dates
1 Sep 2020to 27 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA 1-3;
  • Scheduled for lower laparoscopic abdominal surgery;
  • Ability to give oral and written consent;

Who cannot join

  • Known or suspected neuromuscular disorders impairing neuromuscular function;
  • Allergies to muscle relaxants, anesthetics or narcotics;
  • A (family) history of malignant hyperthermia;
  • Women who are or may be pregnant;
  • Preexisting cardiac disease (any);
  • Untreated or uncontrolled hypertension;
Show all 14Show fewer
  • COPD gold 3 or higher
  • Preexistent esophageal pathology (stricture, tumor, diverticulum)
  • Any increased risk factor for upper gastro intestinal tract bleed:
  • History of GI surgery;
  • History of GI bleed;
  • Esophageal varices;
  • Gastric or esophageal inflammation;
  • Severe thrombocytopenia (less than 50k) or severely elevated INR (>4).

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Leiden University Medical Center

    Leiden

Other trials in Netherlands

About this study

Official title: The Impact of Neuromuscular Relaxation and Nociception Guided Anaesthesia on Hemodynamic Variables During Lower Abdominal Laparoscopic Surgery: a Strategy Trial.

Many surgical procedures are performed using the laparoscopic approach. However, insufflation of the abdomen (pneumoperitoneum) has detrimental hemodynamic effects. The investigators intend to investigate the effect of deep neuromuscular block and nociception guided anaesthesia on hemodynamic variables during pneumoperitoneum for lower abdominal laparoscopic surgery.

Being tested
goal directed anaesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • goal directed anaesthesiaProcedure or surgery

    Deep neuromuscular blockade (PTC 1-2) Nociception level index (NOL) target 10-25

Study groups in NCT04076709
Study groupRoleWhat they receive
Standard CareNo interventionNot described
Goal directed anesthesiaExperimentalDeep neuromuscular blockade (post tetanic count 1-2 twitches) and nociception guided anaesthesia
Receives: Procedure: goal directed anaesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood pressure

    Mean arterial pressure

    Measured: 30 minutes after installation of pneumoperitoneum

Secondary outcomes (5)
  1. Blood pressure

    Mean arterial pressure

    Measured: 5 minutes after installation of pneumoperitoneum

  2. Blood pressure

    Mean arterial pressure

    Measured: 60 minutes after installation of pneumoperitoneum

  3. Cardiac output

    Cardiac output (l/min) as measured by non invasive arterial pulse contour anlysis

    Measured: 5 minutes after installation of pneumoperitoneum

  4. Cardiac output

    Cardiac output (l/min) as measured by non invasive arterial pulse contour anlysis

    Measured: 30 minutes after installation of pneumoperitoneum

  5. Cardiac output

    Cardiac output (l/min) as measured by non invasive arterial pulse contour anlysis

    Measured: 60 minutes after installation of pneumoperitoneum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2019
  2. Study start1 Sep 2020
  3. Primary completion26 Mar 2025
  4. Study completion27 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04076709
Sponsor's protocol ID
P19.042
Acronym
RELAX-LAP
Status last verified
Mar 2025
First submitted
21 Aug 2019
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing goal directed anaesthesia in people with Hemodynamic Instability, run by Leiden University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood pressure (time frame: 30 minutes after installation of pneumoperitoneum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in